Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SeQuent® Please
DEVICE
2 trials
Sponsors
Klinikum Coburg
, B. Braun Medical International Trading Company Ltd.
Conditions
Coronary Instent Restenosis
In-Stent Restenosis
Phase 2
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter
NCT00998439
Klinikum Coburg
In-Stent Restenosis
Start: 2009-10-31
End: 2011-12-31
Target: 120
Updated: 2011-05-20
Phase 3
A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent
Completed
NCT01622075
B. Braun Medical International Trading Company Ltd.
Coronary Instent Restenosis
Start: 2011-03-31
End: 2014-04-30
Updated: 2015-07-24
Related Papers
Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
2016-02-19
9 citations
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
2015-11-01
72 citations
A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis
JACC: Cardiovascular Interventions
2014-02-01
167 citations
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
2012-02-29
257 citations